Page 24 - IJB-4-2
P. 24

The arrival of commercial bioprinters – Towards 3D bioprinting revolution!
















































           Figure 5. Medium-sized Bioprinters: (a) 3DDiscovery™ (courtesy of RegenHU, Fribourg, Switzerland); (B) NovoGen MMX
           Bioprinter™ (courtesy of Organovo, San Diego, United States); (c) FABION (courtesy of 3D Bioprinting Solutions, Russia); (D)
           3D-Bioplotter   (courtesy of Envision TEC, Gladbeck, Germany); (e) BioScaffolder (courtesy of GeSim, Radeberg, Germany); (F)
                     ®
           RX1™ BIOPRINTER (courtesy of Aspect Biosystems, Vancouver, Canada); (G) BIO X (courtesy of CELLINK, Sweden); (H) INVIVO
           (courtesy of Rokit, Seoul, Korea); (i) Allevi 6 (courtesy of Allevi, Philadelphia, US).
           systems: BioAssemblyBot (3D bioprinter) (Figure 6A)   a sophisticated array of sensors and computer vision
           and BioBot™ Basic (Figure 4J). The six-axis robotic   which automatically tunes the printing parameters
           arm of BioAssemblyBot is well complemented by the   for materials [72] . Allevi also offers a wide-range of
                                                                               [73]
           option to load up to ten independent delivery systems   commercial bioinks .
           during a single print run, thus facilitating the fabrication   Aspect Biosystems have been using their proprietary
           of more versatile biological 3D scaffolds. The key   Lab-on-a-Printer™ microfluidic technology in the latest
           highlight lies in the form of its software interface: Tissue   RX1™ bioprinting platform (Figure 5F) [74] . Equipped
           Structure Information Modeling (TSIM). Both systems   with a coaxial flow-focusing technology, which
           also offer features such as rotational stage movement   ensures direct extrusion of biological fibres with varied
           and automated material change.                      diameters. The system was used to demonstrate the
            Allevi (previously called BioBots) has a range     fabrication of an artificial airway, termed 3DBioRingTM.
           of printers (Figure 4A and  Figure 5I) featuring    The airway consists of contractile smooth muscle
           pneumatically-controlled dual-extrusion print heads   tissue comprising of primary human airway smooth
           and visible light technology [71] . Allevi’s systems also   muscle cells. The airway tissue has shown appropriate
           employ an open concept for easy switching between   and reproducible contractions to physiological stimuli
           bioinks and a temperature-controlled extruder head   (histamine) and dilations in response to pharmacological
                                                                               [75]
           (25°C to 120°C). Allevi 6 is WiFi enabled and includes   stimuli (B2-agonist) .

           8                           International Journal of Bioprinting (2018)–Volume 4, Issue 2
   19   20   21   22   23   24   25   26   27   28   29